Ernie Toth joined Aquestive as Interim CFO in December, 2020. Prior to Aquestive he was CFO of EHE Health, a national preventive health, primary care, and telehealth network owned by Summit Partners and DW Healthcare Partners. From January, 2016 to December 2016 he was Chief Financial Officer of ArisGlobal, an end to end drug development platform and from January, 2015 to December, 2015 Global Chief Financial Officer of Synowledge, a global life sciences solutions company providing drug safety, regulatory affairs and IT services to diverse pharmaceutical, biotechnology and medical devices companies. Owned by the Abbhi family, at both ArisGlobal and Synowledge he led Finance, HR, IT, Legal, and Commercial Operations during periods of high growth and the sale of Synowledge to Bioclinica.
Ernie was Chief Financial Officer from 2011 to 2013 of JHP Pharmaceuticals a PE owned (Morgan Stanley Private Investments) integrated specialty healthcare company that develops, manufactures and sells branded and generic aseptic injectable pharmaceuticals and provides contract manufacturing services for global pharmaceutical companies. As CFO, Ernie provided financial and operational leadership through 9 new product launches, 17 ANDA filings, a BARDA award, clinical trials and the sale to Warburg Pincus in 2012.
From 2014 until its sale to a strategic buyer in 2017, Ernie was a member of the Board of Directors of Eska, a leading Canadian beverage company owned by Morgan Stanley Private Investments.
Ernie prior experience includes senior financial leadership positions at Valeritas, Pharmaceutical Formulations, and World Power Technologies. He spent 15 years in various financial positions at MacAndrews & Forbes, the investment company owned by Ronald O. Perelman.
Ernie holds an MBA from Pace University, a BS in Accounting from Shippensburg University of Pennsylvania, and is a CPA in the State of New York.